ARTICLE
15 January 2014

ASC Awaits Changes To OTC Derivatives Regulations

SE
Stikeman Elliott LLP

Contributor

Stikeman Elliott LLP logo
Stikeman Elliott is a global leader in Canadian business law and the first call for businesses working in and with Canada. We provide clients with the highest quality counsel, strategic advice, and creative solutions. Stikeman Elliott consistently ranks as a top law firm in our primary practice areas. www.stikeman.com
The Alberta Securities Commission released a staff notice last week to provide an update on the progress made towards revising the statutory framework for OTC derivatives trading in the province.
Canada Corporate/Commercial Law

The Alberta Securities Commission released a staff notice last week to provide an update on the progress made towards revising the statutory framework for OTC derivatives trading in the province.

Specifically, the fall session of Alberta's legislature ended prior to adoption of Bill 42, which would have amended the province's Securities Act to provide the ASC with the authority to make rules dealing with OTC derivatives. The amendments would also have sought to harmonize Alberta's derivatives regulations with those of other Canadian jurisdictions. Accordingly, until such time that similar legislation is reintroduced, the regulation of OTC derivatives in Alberta will continue under current rules.

As we've previously discussed, amendments related to providing securities regulators with rule-making authority, and rules emanating from the regulators themselves, have recently come into force in Ontario, Quebec and Manitoba.

For more information, see ASC Staff Notice 91-704.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More